Location History:
- Rockville, MA (US) (1998)
- Rockville, MD (US) (1995 - 1999)
Company Filing History:
2 out of 776 
1 out of 1,248 
1 out of 11 Years Active: 1995-1999
Title: Insights into the Innovations of Inventor Chong-Ho Kim
Introduction
Chong-Ho Kim, an innovative inventor based in Rockville, MD, has made significant contributions to the field of targeted therapies. With a total of four patents to his name, his work primarily revolves around advanced methodologies for in-vivo targeting in medical applications.
Latest Patents
Kim's latest innovation involves a sophisticated method for in-vivo binding pair pretargeting. This patented technique facilitates targeting a functional moiety within a patient by administering a targeting moiety that is coupled to an affinity component. The targeting moiety demonstrates a strong affinity for specific binding sites in a targeted area. Following this, a binding partner is introduced to link with the affinity component, enabling localization of the functional moiety in that area. The targeting moiety is preferably an antibody, while the functional moiety is often a radiometal, particularly useful in in-vivo imaging or therapeutic interventions. Furthermore, the affinity component may involve a novel methotrexate analog, which is designed to be thermo-stabilized, thereby enhancing its efficacy.
Career Highlights
Throughout his career, Chong-Ho Kim has been associated with notable companies such as Akzo N.V. and Akzo Nobel N.V. His expertise in biochemistry and targeted therapies has positioned him as an esteemed figure in his field.
Collaborations
In his professional journey, Kim has collaborated with esteemed colleagues, including Reinhard Bredehorst and Richard P. McCabe. These collaborations have contributed to the development and refinement of his patented technologies.
Conclusion
Chong-Ho Kim's innovations in targeted therapies and his ongoing commitment to advancing medical methodologies make him a notable inventor in the field. With his extensive patent portfolio, he continues to influence and drive the future of medical treatment strategies. His contributions not only reflect his expertise but also hold the potential for significant advancements in patient care.